Any drug that substantively delayed or stopped Alzheimer's would be an immediate blockbuster, perhaps exceeding sales for Prozac or Lipitor. No such drugs are on the market because investigators are still trying to understand how to alter the underlying mechanisms by which the disease causes dementia.